Breast cancer cells enticed to spread by 'tumorous environment' as well as genetic changes

October 22, 2012
Breast cancer cells enticed to spread by 'tumorous environment' as well as genetic changes
Two pieces of the same human metastatic breast tumor acted very differently depending on their protein environments. Breast tumor cells in a tumorous environment (left) rapidly exited the tumor fragment. Breast tumor cells in a healthy environment (right) grew in a controlled manner. Credit: Kevin Cheung, M.D.

(Medical Xpress)—A new study from Johns Hopkins researchers suggests that the lethal spread of breast cancer is as dependent on a tumor's protein-rich environment as on genetic changes inside tumor cells.

In a report in the Sept. 25 issue of the , the scientists conclude that a molecular signal in the protein meshwork surrounding the may provide the critical trigger to initiate the life-threatening process of metastasis to distant sites in the body.

Moreover, their experiments suggest that the environment surrounding a tumor can even coax healthy to invade surrounding tissue just as cancer cells do, and that a healthy environment can cause cancer cells to stay put and not spread as they usually do.

"The most dangerous aspect of is its ability to spread to distant sites, and most tumors are initially unable to do that," says Andrew Ewald, Ph.D., assistant professor of at the Johns Hopkins School of Medicine and member of the Institute for Basic Biomedical Sciences' Center for . Learning more specifically what triggers metastases may provide additional targets for preventing and treating the malignant process that causes cancer deaths, Ewald adds.

It's widely accepted that cancers acquire the ability to spread through the gradual accumulation of , and experiments have also shown that these changes occur in parallel with changes in the and 3-dimensional patterning of the protein meshwork that creates their immediate surroundings. What has been unclear is whether those immediate surroundings play a role in initiating and encouraging cancer's spread, or whether they are more "effect" then "cause."

To sort out the contributions of both the genetic changes and the environment, Ewald's team separated from their surroundings by taking fragments of human breast tumors and embedding them in two different commercially available 3-D gels, one that mimics the protein meshwork surrounding healthy mammary tissue and another that mimics tumorous mammary tissue.

The gels are tools often used to study tumor invasiveness. The first was made of proteins that normally create a thin layer around healthy breast tissue, acting as a molecular boundary for it. The second was made entirely of a protein, collagen I, which is found in unusually high concentrations around .

If cancer cells are driven to disperse solely because of the genetic changes they carry, the researchers expected to see the tumor fragments behave similarly in both the healthy and tumorous environments. What they saw instead, says Ewald, was a distinct difference. As expected, 88 percent of tumor fragments sent cells crawling into the tumorous meshwork environment, the first step in metastasis known as dissemination. (See video) But only 15 percent of tumor fragments sent cells crawling into the normal environment. (See video) According to Ewald, these results indicate that the environment around a tumor plays a more direct role in cancer spread than previously thought.

If indeed cells can be enticed outward by the protein environment, the researchers reasoned, that environment might even be powerful enough to coax cells away from healthy breast tissue. To test this idea, they took fragments of both healthy and cancerous mouse mammary glands and placed them in the collagen I gels mimicking a tumor's environment. Results show that in the tumorous environment, nearly as many of the healthy fragments sent cells dispersing (See video) as did the tumorous fragments (See video).

One notable difference shown in their time-lapse videos was that healthy cells only exited the normal tissue fragments for a short period of time, while continued to exit the tumor fragments throughout the whole test period.

To learn why healthy cells stopped exiting normal tissue fragments sooner, the researchers analyzed the proteins on the cells that were in direct contact with the meshwork gels. In breast tissue, a thin protein layer normally forms a boundary between cells and their environment. When both healthy and tumorous tissue fragments were surgically removed prior to the experiments, this boundary was disrupted, allowing breast to directly contact the protein meshwork beyond the boundary. In healthy mammary gland fragments, the team found that the "self-corrective behavior" coincided with the re-creation of this protein boundary.

"This tells us that tumors continue to listen to their environments," Ewald says. "Our data suggest that tumors with genetic changes that favor cancer spread may not disperse until they are within a permissive environment." A dispersal-permissive is enough to provoke invasive behavior in all mammary tissue, healthy and cancerous, Ewald explains, and the difference between the two can be a single genetic change that allows the dispersal to continue unchecked.

Explore further: Researchers discover protein that could help prevent the spread of cancer

Related Stories

Researchers discover protein that could help prevent the spread of cancer

May 4, 2011
A protein capable of halting the spread of breast cancer cells could lead to a therapy for preventing or limiting the spread of the disease.

Ovarian cancer cells hijack surrounding tissues to enhance tumor growth

September 4, 2012
Tumor growth is dependent on interactions between cancer cells and adjacent normal tissue, or stroma. Stromal cells can stimulate the growth of tumor cells; however it is unclear if tumor cells can influence the stroma.

Research makes significant cancer breakthrough

August 8, 2012
(Medical Xpress) -- A major breakthrough by scientists at Queen's University Belfast could lead to more effective treatments for throat and cervical cancer. The discovery could see the development of new therapies, which ...

Endotrophin links obesity to breast cancer progression

October 8, 2012
Fat cells (adipocytes) surround breast tumors and contribute to tumor growth by expressing factors that aid oncogenesis. Col6 is a protein that is highly expressed in adipocytes and its expression is further increased in ...

Recommended for you

Researchers compose guidelines for handling CAR T cell side effects

September 19, 2017
Immune-cell based therapies opening a new frontier for cancer treatment carry unique, potentially lethal side effects that provide a new challenge for oncologists, one addressed by a team led by clinicians at The University ...

Altitude training for cancer-fighting cells

September 18, 2017
Mountain climbers and endurance athletes are not the only ones to benefit from altitude training - that is, learning to perform well under low-oxygen conditions. It turns out that cancer-fighting cells of the immune system ...

Metabolism can be used to subtype hepatoblastoma tumors

September 18, 2017
Looking at cell metabolism instead of histology, EPFL scientists have identified new biomarkers that could help more accurately classify the two main subtypes of hepatoblastoma, a children liver cancer.

A new paradigm for treating transcription factor-driven cancers

September 18, 2017
In the current issue of Proceedings of the National Academy of Sciences, researchers from Nationwide Children's Hospital describe a new paradigm for treating transcription factor-driven cancers. The study focuses on Ewing ...

Scientists find bacteria in pancreatic tumors that metabolize a common drug

September 15, 2017
To the reasons that chemotherapy sometimes does not work, we can now add one more: bacteria. In a study published today in Science, researchers describe findings that certain bacteria can be found inside human pancreatic ...

New technologies combined to identify specific DNA defect underlying a type of cancer

September 15, 2017
(Medical Xpress)—A team of researchers from the Netherlands and the U.K. has developed a technique for studying inherited types of cancers using two relatively new technologies—organoid development and CRISPR/Cas9. In ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.